Prognostic impact of abdominal adiposity, waist circumference and body mass index in patients with intermediate-risk prostate cancer treated with radiotherapy

International Journal of Obesity

Volumn 35, Issue 11, 2011, Pages 1421-1426

  Zilli, T ^a   Nguyen, T V ^a   Bahary, J P ^a   Chagnon, M ^a   Dufresne, A ^a   Taussky, D ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

abdominal fat; body mass index; prostate cancer; radiation therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DISEASE MARKER; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; UNIVARIATE ANALYSIS; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY, IMAGE-GUIDED; RISK FACTORS; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 81155134839     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.279     Document Type: Article

References (36)

1. Amling CL, Riffenburgh RH, Sun L, Moul JW, Lance RS, Kusuda L et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 2004; 22: 439-445. (Pubitemid 41079772)
2. Kane CJ, BassettWW, Sadetsky N, Silva S,Wallace K, Pasta DJ et al. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE. J Urol 2005; 173: 732-736. (Pubitemid 40239329)
3. Freedland SJ, Aronson WJ, Kane CJ, Presti Jr JC, Amling CL, Elashoff D et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 2004; 22: 446-453. (Pubitemid 41079773)
4. Freedland SJ, Grubb KA, Yiu SK, Humphreys EB, Nielsen ME, Mangold LA et al. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center. J Urol 2005; 174: 919-922. (Pubitemid 41140631)
5. Strom SS, Wang X, Pettaway CA, Logothetis CJ, Yamamura Y, Do KA et al. Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Clin Cancer Res 2005; 11: 6889-6894. (Pubitemid 41428745)
6. Efstathiou JA, Chen MH, Renshaw AA, Loffredo MJ, D'Amico AV. Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer. Cancer 2007; 109: 1493-1498. (Pubitemid 46595683)
7. Palma D, Pickles T, Tyldesley S. Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer. BJU Int 2007; 100: 315-319. (Pubitemid 47036558)
8. Strom SS, Kamat AM, Gruschkus SK, Gu Y, Wen S, Cheung MR et al. Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer 2006; 107: 631-639. (Pubitemid 44107225)
9. Stroup SP, Cullen J, Auge BK, L0Esperance JO, Kang SK. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006. Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition. Cancer 2007; 110: 1003-1009. (Pubitemid 47312865)
10. Loeb S, Yu X, Nadler RB, Roehl KA, Han M, Hawkins SA et al. Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy? J Urol 2007; 177: 102-106; discussion 106. (Pubitemid 44895330)
11. Mallah KN, DiBlasio CJ, Rhee AC, Scardino PT, Kattan MW. Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy. Cancer 2005; 103: 2030-2034. (Pubitemid 40605109)
12. Efstathiou JA, Skowronski RY, Coen JJ, Grocela JA, Hirsch AE, Zietman AL. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008; 71: 1302-1308.
13. Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen Z, Lief JH et al. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy. Urology 2005; 65: 95-100. (Pubitemid 40169613)
14. Merrick GS, Galbreath RW, Butler WM, Wallner KE, Allen ZA, Adamovich E. Obesity is not predictive of overall survival following permanent prostate brachytherapy. Am J Clin Oncol 2007; 30: 588-596. (Pubitemid 350307183)
15. Soete G, Verellen D, Storme G. Image guided radiotherapy for prostate cancer. Bull Cancer 2008; 95: 374-380. (Pubitemid 351528777)
16. von Hafe P, Pina F, Perez A, Tavares M, Barros H. Visceral fat accumulation as a risk factor for prostate cancer. Obes Res 2004; 12: 1930-1935.
17. Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM,Wallace RB. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 1990; 131: 794-803. (Pubitemid 20133921)
18. Moon HG, Ju YT, Jeong CY, Jung EJ, Lee YJ, Hong SC et al. Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 2008; 15: 1918-1922.
19. Oh TH, Byeon JS, Myung SJ, Yang SK, Choi KS, Chung JW et al. Visceral obesity as a risk factor for colorectal neoplasm. J Gastroenterol Hepatol 2008; 23: 411-417.
20. Schapira DV, Kumar NB, Lyman GH, Cavanagh D, Roberts WS, LaPolla J. Upper-body fat distribution and endometrial cancer risk. JAMA 1991; 266: 1808-1811.
21. Chandra A, Dong L, Huang E, Kuban DA, O0Neill L, Rosen I et al. Experience of ultrasound-based daily prostate localization. Int J Radiat Oncol Biol Phys 2003; 56: 436-447. (Pubitemid 36546257)
22. Roach III M, Hanks G, Thames Jr H, Schellhammer P, Shipley WU, Sokol GH et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus conference. Int J Radiat Oncol Biol Phys 2006; 65: 965-974.
23. Ray ME, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA et al. PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis. Int J Radiat Oncol Biol Phys 2006; 64: 1140-1150.
24. Kuk JL, Lee S, Heymsfield SB, Ross R. Waist circumference and abdominal adipose tissue distribution: influence of age and sex. Am J Clin Nutr 2005; 81: 1330-1334. (Pubitemid 41710234)
25. Schoen RE, Thaete FL, Sankey SS, Weissfeld JL, Kuller LH. Sagittal diameter in comparison with single slice CT as a predictor of total visceral adipose tissue volume. Int J Obes Relat Metab Disord 1998; 22: 338-342. (Pubitemid 28138440)
26. Baumgartner RN, Heymsfield SB, Roche AF, Bernardino M. Abdominal composition quantified by computed tomography. Am J Clin Nutr 1988; 48: 936-945.
27. Borkan GA, Gerzof SG, Robbins AH, Hults DE, Silbert CK, Silbert JE. Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 1982; 36: 172-177. (Pubitemid 12000247)
28. Bittner N, Merrick GS, Stewart R, Andreini H, Taubenslag W, Curtis R et al. Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate. Urol Oncol 2009 (in press).
29. Millender LE, Aubin M, Pouliot J, Shinohara K, Roach III M. Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004; 59: 6-10. (Pubitemid 38501501)
30. Wong JR, Gao Z, Merrick S, Wilson P, Uematsu M, Woo K et al. Potential for higher treatment failure in obese patients: correlation of elevated body mass index and increased daily prostate deviations from the radiation beam isocenters in an analysis of 1465. computed tomographic images. Int J Radiat Oncol Biol Phys 2009; 75: 49-55.
31. Serago CF, Chungbin SJ, Buskirk SJ, Ezzell GA, Collie AC, Vora SA. Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy. Int J Radiat Oncol Biol Phys 2002; 53: 1130-1138. (Pubitemid 34787847)
32. Scarbrough TJ, Golden NM, Ting JY, Fuller CD,Wong A, Kupelian PA et al. Comparison of ultrasound and implanted seed marker prostate localization methods: implications for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2006; 65: 378-387.
33. Little DJ, Dong L, Levy LB, Chandra A, Kuban DA. Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: implications for treatment margins. Int J Radiat Oncol Biol Phys 2003; 56: 1218-1224. (Pubitemid 36842871)
34. Freedland SJ, Banez LL, Sun LL, Fitzsimons NJ, Moul JW. Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database. Prostate Cancer Prostatic Dis 2009; 12: 259-263.
35. Hammarsten J, Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001; 39: 151-158. (Pubitemid 32171181)
36. Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O'Donnell CJ, Hoffmann U. Comparison of anthropometric, area-and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multidetector computed tomography. Int J Obes (Lond) 2007; 31: 500-506.